Connors Investor Services Inc Amgen Inc Transaction History

Connors Investor Services Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 10, 2019	SELL	$180.87 - $203.88 $193,530 - $218,151	-1,070 Closed	0 $0
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $10,168 - $11,870	-57 Reduced 5.06%	1,070 $208,000
Q3 2018 Nov 13, 2018	BUY	$185.29 - $208.89 $4,076 - $4,595	22 Added 1.99%	1,127 $234,000
Q2 2018 Aug 13, 2018	BUY	$166.05 - $186.51 $183,485 - $206,093	1,105 New	1,105 $204,000
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $186,512 - $208,391	-1,105 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $184,855 - $211,055	1,105	1,105 $206,000

3,084

417M

7.18M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Connors Investor Services Inc, based on Form 13F filings with the SEC.

Stay updated on Connors Investor Services Inc with notifications on news.